Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market

Pasithea Therapeutics Corp (KTTA) Technical Analysis

29 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Pasithea Therapeutics Corp’s (KTTA) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Pasithea Therapeutics Corp is a Sell.
Pasithea Therapeutics Corp’s (KTTA) 20-Day exponential moving average is 5.61, while Pasithea Therapeutics Corp’s (KTTA) share price is $5.79, making it a Buy.
Pasithea Therapeutics Corp’s (KTTA) 50-Day exponential moving average is 5.84, while Pasithea Therapeutics Corp’s (KTTA) share price is $5.79, making it a Sell.

Pasithea Therapeutics Corp (KTTA) Pivot Points

Jul 24, 2024, 10:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.25
5.55
5.70
6.00
6.15
6.45
6.60
Fibonacci
5.55
5.72
5.83
6.00
6.17
6.28
6.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pasithea Therapeutics Corp (KTTA) Moving Averages

Jul 24, 2024, 10:27 AM
Period
Simple
Exponential
MA5
5.92Sell
5.84Sell
MA10
5.73Buy
5.73Buy
MA20
5.45Buy
5.61Buy
MA50
5.78Buy
5.84Sell
MA100
6.56Sell
6.35Sell
MA200
6.89Sell
7.24Sell
Pasithea Therapeutics Corp’s (KTTA) 10-Day exponential moving average is 5.73, while Pasithea Therapeutics Corp’s (KTTA) share price is $5.79, making it a Buy.
Pasithea Therapeutics Corp’s (KTTA) 100-Day exponential moving average is 6.35, while Pasithea Therapeutics Corp’s (KTTA) share price is $5.79, making it a Sell.
Pasithea Therapeutics Corp’s (KTTA) stock price is $5.79 and Pasithea Therapeutics Corp’s (KTTA) 50-day simple moving average is 5.78, creating a Buy signal.
Pasithea Therapeutics Corp’s (KTTA) stock price is $5.79 and Pasithea Therapeutics Corp’s (KTTA) 100-day simple moving average is 6.56, creating a Sell signal.
Pasithea Therapeutics Corp’s (KTTA) stock price is $5.79 and Pasithea Therapeutics Corp’s (KTTA) 200-day simple moving average is 6.89, creating a Sell signal.

Pasithea Therapeutics Corp (KTTA) Technical Indicators

Jul 24, 2024, 10:27 AM
Name
Value
Implied Action
RSI (14)
54.21
Neutral
STOCH (9,6)
56.35
Neutral
STOCHRSI (14)
65.06
Neutral
MACD (12,26)
0.07
Sell
ADX (14)
18.13
Buy
Williams %R
-39.90
Buy
CCI (14)
77.48
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
55.33
Neutral
ROC
10.48
Buy
Pasithea Therapeutics Corp’s (KTTA) Relative Strength Index (RSI) is 54.21, creating a Neutral signal.
Pasithea Therapeutics Corp’s (KTTA) Trend Strength Indicator (ADX) is 18.13, creating a Buy signal.
Pasithea Therapeutics Corp’s (KTTA) Commodity Channel Index (CCI) is 77.48, creating a Neutral signal.
Pasithea Therapeutics Corp’s (KTTA) Price Rate of Change (ROC) is 10.48, creating a Buy signal.

FAQ

Is KTTA a Buy, Hold, or Sell?
Based on KTTA’s technical indicators, KTTA is a Hold.
    What is KTTA’s RSI (14)?
    KTTA’s RSI (14) is 54.21, which suggests KTTA is a Neutral.
      What is KTTA’s MACD?
      KTTA’s MACD is 0.07, which suggests KTTA is a Sell.
        What is KTTA’s 5-day moving average?
        KTTA’s 5-day moving average is 5.92, which suggests KTTA is a Sell.
          What is KTTA’s 20-day moving average?
          KTTA 20-day moving average is 5.45, which suggests KTTA is a Buy.
            What is KTTA’s 50-day moving average?
            KTTA’s 50-day moving average is 5.78, which suggests KTTA is a Buy.
              What is KTTA’s 200-day moving average?
              KTTA’s 200-day moving average is 6.89, which suggests KTTA is a Sell.
                What is KTTA’s Williams % R (14)?
                KTTA’s Williams % R (14) is -39.90, which suggests KTTA is a Buy.
                  What is KTTA’s CCI (14)?
                  KTTA’s CCI (14) is 77.48, which suggests KTTA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis